These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36842094)

  • 41. Conjugated linoleic acid modulates immune responses in patients with mild to moderately active Crohn's disease.
    Bassaganya-Riera J; Hontecillas R; Horne WT; Sandridge M; Herfarth HH; Bloomfeld R; Isaacs KL
    Clin Nutr; 2012 Oct; 31(5):721-7. PubMed ID: 22521469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential stimulation of peripheral blood mononuclear cells in Crohn's disease by fungal glycans.
    Baram L; Cohen-Kedar S; Spektor L; Elad H; Guzner-Gur H; Dotan I
    J Gastroenterol Hepatol; 2014 Dec; 29(12):1976-84. PubMed ID: 25092526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis.
    Boirivant M; Marini M; Di Felice G; Pronio AM; Montesani C; Tersigni R; Strober W
    Gastroenterology; 1999 Mar; 116(3):557-65. PubMed ID: 10029614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Mechanosensitive Ion Channel PIEZO1 in Intestinal Epithelial Cells Mediates Inflammation through the NOD-Like Receptor 3 Pathway in Crohn's Disease.
    Liu Q; Wang D; Yang X; Ma F; Han W; Hu J; Mei Q
    Inflamm Bowel Dis; 2023 Jan; 29(1):103-115. PubMed ID: 35907203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations in the function of circulating mononuclear cells derived from patients with Crohn's disease treated with mastic.
    Kaliora AC; Stathopoulou MG; Triantafillidis JK; Dedoussis GV; Andrikopoulos NK
    World J Gastroenterol; 2007 Dec; 13(45):6031-6. PubMed ID: 18023095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral monocyte functions and activation in patients with quiescent Crohn's disease.
    Schwarzmaier D; Foell D; Weinhage T; Varga G; Däbritz J
    PLoS One; 2013; 8(4):e62761. PubMed ID: 23658649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
    Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
    World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating CD4(+)CXCR5(+) T Cells Exacerbate B Cell Antibody Production in Crohn's Disease Through IL-21 Secretion.
    Wang Z; Ding L; Wang Z; Wang J; Zhu N; Diao Y; Demmy TA; Haitsma JM; Lech-Maranda EE; Bangia NN; Czuczman MA; Qian X; Kovacs KL
    Immunol Invest; 2015; 44(7):665-77. PubMed ID: 26436852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease.
    Poturoglu S; Kaymakoglu S; Gurel Polat N; Ibrisim D; Ahishali E; Akyuz F; Badur S; Demir K; Mungan Z
    Scand J Clin Lab Invest; 2009; 69(6):696-702. PubMed ID: 19452347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
    Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
    Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
    Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
    Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deregulated NLRP3 and NLRP1 inflammasomes and their correlations with disease activity in systemic lupus erythematosus.
    Yang Q; Yu C; Yang Z; Wei Q; Mu K; Zhang Y; Zhao W; Wang X; Huai W; Han L
    J Rheumatol; 2014 Mar; 41(3):444-52. PubMed ID: 24334646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients.
    Włodarczyk M; Sobolewska A; Wójcik B; Loga K; Fichna J; Wiśniewska-Jarosińska M
    World J Gastroenterol; 2014 Jun; 20(22):7019-26. PubMed ID: 24944497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Expression of Inflammasomes NLRP1 and NLRP3, Toll-Like Receptors, and Vitamin D Receptor in Synovial Fibroblasts From Patients With Different Types of Knee Arthritis.
    Sakalyte R; Denkovskij J; Bernotiene E; Stropuviene S; Mikulenaite SO; Kvederas G; Porvaneckas N; Tutkus V; Venalis A; Butrimiene I
    Front Immunol; 2021; 12():767512. PubMed ID: 35126351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.
    Kucharzik T; Lügering N; Weigelt H; Adolf M; Domschke W; Stoll R
    Clin Exp Immunol; 1996 Jun; 104(3):483-90. PubMed ID: 9099934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased expression of costimulatory molecules on peripheral blood monocytes in patients with Crohn's disease.
    Liu ZX; Hiwatashi N; Noguchi M; Toyota T
    Scand J Gastroenterol; 1997 Dec; 32(12):1241-6. PubMed ID: 9438323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.
    Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Piqué JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C
    J Immunol; 2006 Feb; 176(4):2617-24. PubMed ID: 16456024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mycobacterium avium subsp. Paratuberculosis (MAP) as a modifying factor in Crohn's disease.
    Sibartie S; Scully P; Keohane J; O'Neill S; O'Mahony J; O'Hanlon D; Kirwan WO; O'Mahony L; Shanahan F
    Inflamm Bowel Dis; 2010 Feb; 16(2):296-304. PubMed ID: 19824071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease.
    Bauditz J; Haemling J; Ortner M; Lochs H; Raedler A; Schreiber S
    Gut; 1997 Apr; 40(4):470-4. PubMed ID: 9176073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.